Stryker Corporation

SYKNYSEHealthcare● Active

$305.66

+$4.45(+1.48%)

Market Cap$117.2B

P/E Ratio—

52W High$404.87

52W Low$281

Avg Volume2.5M

Open$305.61

Beta0.79

Free Cash Flow Financials Revenue

Stryker Corporation (SYK) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

SYK · free cash flow · updated Jun 8, 2026

Core FCF metrics

SYK · FCF · TTM · margin & CAGR

Free cash flow was $4.28B for FY2025 (fiscal year ending 2025-12-31), up 22.8% year-over-year The FCF margin was 17.1%. Five-year CAGR stands at +8.9%.

FY2025 Free Cash Flow$4.28B▲ +22.8% YoY

Trailing 12M (TTM)$4.57Btrailing 4 quarters sum

FCF Margin17.1%$4.28B ÷ revenue

3-Year CAGR+28.1%FY2022 → FY2025

5-Year CAGR+8.9%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

SYK · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$5.04B(761M)$4.28B▲ +22.8%17.1%

FY2024$4.24B(755M)$3.49B▲ +11.2%15.4%

FY2023$3.71B(575M)$3.14B▲ +54.0%15.3%

FY2022$2.62B(588M)$2.04B▼ 25.6%11.0%

FY2021$3.26B(525M)$2.74B▼ 1.9%16.0%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

SYK · P/FCF · FCF yield · FCF per share

Stryker Corporation (SYK) trades at a FCF yield of 3.90% and a price-to-free-cash-flow ratio of 25.6x. FCF per share stands at $11.96, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

3.90%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$11.96

TTM FCF ÷ Shares Outstanding

Price / FCF

x25.6

Share Price ÷ FCF per Share

EV / FCF (TTM)

x28.1

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

SYK · cash flow statement · operating / investing / financing

For FY2025, Stryker Corporation generated $5.04B in operating cash flow and spent 761M in capital expenditures, yielding $4.28B in free cash flow.

Operating Activities

+$5.04B

Cash from core business operations

2025-12-31

Investing Activities

−$4.87B

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$113.0M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($5.04B) − |CapEx| (761M) = FCF ($4.28B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

SYK vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Stryker CorporationYOU

SYK

$4.28B+22.8%17.1%

22%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Stryker Corporation (SYK) reported free cash flow of $4.28B for FY2025 (fiscal year ending 2025-12-31), up 22.8% year-over-year. The FCF margin was 17.1%.

Based on available data, Stryker Corporation has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $4.28B in FY2025. The 5-year CAGR stands at +8.9%.

Stryker Corporation's FCF yield is 3.90% and price-to-FCF ratio is 25.6x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

SYK free cash flow · 8 questions

Stryker Corporation free cash flow was $4.28B for FY2025, up 22.8% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $4.57B.

SYK free cash flowSYK FCFSYK FCF 2025SYK free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Stryker Corporation · Stryker Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026